TriMarkPublications.com cites in its new report, "Bioseparation Systems for Global Biopharmaceutical Markets," that the global market for bioseparation systems for biopharmaceutical manufacturing will jump to $6 billion by 2018. While North America and Europe will continue to account for a significant share of revenue, the emerging countries of China, India, Brazil and Russia are rapidly increasing share, growing at a CAGR of 22%.
The demand for single use products is increasing and fueling growth of the global bioseparation systems market. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. The Asian countries of India, Singapore, South Korea and China are fast becoming biomanufacturing hubs, producing biosimilars for their own large populations and for Southeast Asia.
The "Bioseparation Systems for Global Biopharmaceutical Markets" report covers:
- Single use products
- Manufacturing capacity
- Applications of bioseparation systems in downstream processing
- Downstream processing bottlenecks
- Emerging bioseparation system technologies
- Manufacturing capacity by biopharmaceutical company, CMO and region